Sagimet Biosciences Inc. Series A (NASDAQ:SGMT – Get Free Report) and BeiGene (NASDAQ:BGNE – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends. Profitability This table compares Sagimet Biosciences […]
Sagimet Biosciences Inc. Series A’s (NASDAQ:SGMT – Get Free Report) quiet period is set to end on Wednesday, August 23rd. Sagimet Biosciences Inc. Series A had issued 5,312,500 shares in its public offering on July 14th. The total size of the offering was $85,000,000 based on an initial share price of $16.00. During the company’s […]
Equities research analysts at TD Cowen started coverage on shares of Sagimet Biosciences Inc. Series A (NASDAQ:SGMT – Get Free Report) in a report released on Tuesday, Briefing.com reports. The brokerage set an “outperform” rating on the stock. SGMT has been the subject of several other reports. JMP Securities assumed coverage on shares of Sagimet […]
Equities researchers at TD Cowen began coverage on shares of Sagimet Biosciences Inc. Series A (NASDAQ:SGMT – Get Free Report) in a report released on Tuesday, Briefing.com reports. The firm set an “outperform” rating on the stock. Several other analysts have also recently commented on SGMT. JMP Securities initiated coverage on shares of Sagimet Biosciences […]